TY - JOUR
T1 - Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation
T2 - A systematic review and meta-analysis
AU - Cheungpasitporn, Wisit
AU - Thongprayoon, Charat
AU - Harindhanavudhi, Tasma
AU - Edmonds, Peter J.
AU - Erickson, Stephen B.
PY - 2016/4/2
Y1 - 2016/4/2
N2 - Abstract: Background: New-onset diabetes after kidney transplantation (NODAT) is associated with both renal allograft failure and increased mortality. The objective of this meta-analysis was to evaluate the risk of NODAT in patients with hypomagnesemia. Methods: A literature search was performed using MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from inception through May, 2015. Studies that reported relative risks, odd ratios or hazard ratios comparing the risk of NODAT in patients with hypomagnesemia were included. Pooled risk ratios (RR) and 95% confidence interval (CI) were calculated using a random-effect, generic inverse variance method. Results: Five cohort studies with 1699 patients were included in the analysis to assess the risk of NODAT in patients with hypomagnesemia. The pooled RR of NODAT in patients with hypomagnesemia was 1.25 (95% CI, 1.08–1.45). When meta-analysis was limited only to studies with the post-transplant hypomagnesemia, the pooled RR of NODAT was 1.22 (95% CI, 1.09–1.38). Conclusion: Our meta-analysis demonstrates a significant association between hypomagnesemia and NODAT in kidney transplant recipients. This finding suggests the need for a large randomized controlled trial–with very careful attention to assess the effects of normalizing Mg levels and the risk of NODAT.
AB - Abstract: Background: New-onset diabetes after kidney transplantation (NODAT) is associated with both renal allograft failure and increased mortality. The objective of this meta-analysis was to evaluate the risk of NODAT in patients with hypomagnesemia. Methods: A literature search was performed using MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from inception through May, 2015. Studies that reported relative risks, odd ratios or hazard ratios comparing the risk of NODAT in patients with hypomagnesemia were included. Pooled risk ratios (RR) and 95% confidence interval (CI) were calculated using a random-effect, generic inverse variance method. Results: Five cohort studies with 1699 patients were included in the analysis to assess the risk of NODAT in patients with hypomagnesemia. The pooled RR of NODAT in patients with hypomagnesemia was 1.25 (95% CI, 1.08–1.45). When meta-analysis was limited only to studies with the post-transplant hypomagnesemia, the pooled RR of NODAT was 1.22 (95% CI, 1.09–1.38). Conclusion: Our meta-analysis demonstrates a significant association between hypomagnesemia and NODAT in kidney transplant recipients. This finding suggests the need for a large randomized controlled trial–with very careful attention to assess the effects of normalizing Mg levels and the risk of NODAT.
KW - Electrolytes
KW - graft
KW - hypomagnesaemia
KW - hypomagnesemia
KW - kidney
KW - magnesium
KW - meta-analysis
KW - new-onset diabetes
KW - transplantation
UR - http://www.scopus.com/inward/record.url?scp=84961211975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961211975&partnerID=8YFLogxK
U2 - 10.3109/07435800.2015.1094088
DO - 10.3109/07435800.2015.1094088
M3 - Article
C2 - 26934195
AN - SCOPUS:84961211975
SN - 0743-5800
VL - 41
SP - 142
EP - 147
JO - Endocrine Research
JF - Endocrine Research
IS - 2
ER -